RECCE PHARMACEUTICALS LTD - News & Media

21.9%

44.5¢

Market Cap $128.6M

Healthcare Biotechnology

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight

Recce accelerates commercialisation

Articles & Videos

Recce locks in $30M to boost commercialisation across ASEAN region

Recce Pharmaceuticals (ASX:RCE) has secured the first tranche of a $30M debt facility to continue running skin infection...

17 Jun 2025 15:59 (AEST)

'Critical step': Go for Recce's Phase III trials after banking $15.8M in capital raise

Recce Pharmaceuticals (ASX:RCE) has successfully filled its coffers ahead of its Phase III clinical trials in Indonesia and Australia, with the company this week landing @firm commitments” to place the full shortfall in its capital raise.Listen to the HotCopper podcast for i...

04 Jun 2025 09:29 (AEST)

Recce adds 20 more people to trial for R327G foot gel

Recce Pharmaceuticals Ltd has received Human Ethics Approval to add 20 more patients with diabetic foot infections to its clinical trial

22 Apr 2025 14:04 (AEST)

Recce to raise $15.8M in trial funds through placement, entitlement offer

Recce Pharmaceuticals Ltd plans to raise $5 million through a Placement to a private investor in Australia, and an Entitlement Offer

10 Apr 2025 13:17 (AEST)

Recce finds foot gel to be efficacious in Phase II clinical trial

Recce Pharmaceuticals Ltd has taken positive results from its Phase II clinical trial into topic gel R327G.

17 Feb 2025 11:28 (AEDT)

'Significant' new milestone for Recce in clinical testing of skin infection gel

Recce Pharmaceuticals Ltd has seen its share price rise more than 1% as it completes dosing of all 30 participants

21 Jan 2025 15:07 (AEDT)

Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial

Recce Pharmaceuticals Ltd has secured approval for a Phase 3 trial on its treatment candidate to treat diabetic foot infections

09 Dec 2024 10:18 (AEDT)

Complete patent protection for 2 Recce anti-infective treatments

Recce Pharmaceuticals Ltd (ASX:RCE) has ticked off completion of all patents for two of its key anti-infectives, with the Australian Patent Office granting @Patent Family 3’ status to RECCE 327 (R327) and RECCE 529 (R529).The latest patent @ which expires in 2037 @ covers the proc...

26 Nov 2024 10:07 (AEDT)

Recce scores $6.75M R&D rebate

Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.

14 Nov 2024 16:29 (AEDT)

Recce reaches key dosing milestone in testing of skin infection gel

Recce Pharmaceuticals Ltd has successfully dosed 20 out of 30 participants in its Phase II trial to test the RECCE 327 gel for skin infections

05 Nov 2024 12:59 (AEDT)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 44.5¢		Change 0.080(21.9%)		Mkt cap ! $128.6M

Open	High	Low	Value	Volume
37.5¢	44.5¢	37.5¢	$191.2K	477.3K

Buyers (Bids)

No.	Vol.	Price($)
2	12222	44.0¢

Sellers (Offers)

Price($)	Vol.	No.
45.0¢	10976	2

View Market Depth

No.	Vol.	Price($)
2	12222	0.440
2	8000	0.425
1	50000	0.420
1	4175	0.415
2	69894	0.400

Price($)	Vol.	No.
0.450	10976	2
0.460	14304	2
0.470	100000	1
0.490	8000	1
0.500	13381	3

Last trade - 16.10pm 25/07/2025 (20 minute delay)

RCE (ASX) Chart